UAB "Via pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
258,733 |
86,244 |
32,764 |
27,849 |
9,283 |
0.37 |
0.87 |
44.94 |
10.76 |
96,400 |
83,995 |
721 |
179,674 |
2022 |
---|
114,039 |
38,013 |
10,310 |
8,763 |
2,921 |
0.83 |
0.84 |
51.84 |
7.68 |
95,163 |
79,973 |
221 |
174,915 |
2023 |
---|
49,866 |
14,975 |
-19,824 |
-19,824 |
-5,953 |
1.51 |
0.81 |
37.54 |
-39.75 |
75,338 |
60,661 |
1 |
135,998 |
Register and
explore Okredo data2023 |
---|
49,866 |
14,975 |
-19,824 |
-19,824 |
-5,953 |
1.51 |
0.81 |
37.54 |
-39.75 |
75,338 |
60,661 |
1 |
135,998 |
Register and
explore Okredo data2023
Turnover (€)
49,866 €-56 % *
Sales per employee (€)
14,975 €-61 % *
Profit before tax (€)
-19,824 €-292 % *
Net Profit (€)
-19,824 €-326 % *
Profit per employee (€)
-5,953 €-304 % *
Working capital requirement
1.51 81.93 % *
Debt-to-equity ratio
0.81 -3.57 % *
Total profitability (%)
37.54 %-27.58 % *
Net profitability (%)
-39.75 %-617.58 % *
Equity (€)
75,338 €-21 % *
Amounts Payable And Liabilities (€)
60,661 €-24 % *
Non-current Assets (€)
1 €-100 % *
CurrentAssets (€)
135,998 €-22 % *